Dr Samuel Chamberlain MB/BChir PhD MRCPsych

Collaborators

Key publications

Chamberlain SR, Fineberg NA, Menzies LA, Blackwell AD, Bullmore ET, Robbins TW, Sahakian BJ (2007), “Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder” Am J Psychiatry 164(2):335-8 Details

Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ (2006), “Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania” Am J Psychiatry 163(7):1282-4 Details

Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2006), “Neurochemical modulation of response inhibition and probabilistic learning in humans” Science 311(5762):861-3 Details

Publications

2013

Chamberlain SR (2013), “Modafinil, inhibitory control, and alcoholism.” Biol Psychiatry 73(3):207-8 Details

Chamberlain SR, Odlaug BL, Schreiber LR, Grant JE (2013), “Clinical and neurocognitive markers of suicidality in young adults.” J Psychiatr Res 47(5):586-91 Details

Chamberlain SR, Robbins TW (2013), “Noradrenergic modulation of cognition: Therapeutic implications.” J Psychopharmacol Details

Grant JE, Odlaug BL, Schreiber LR, Chamberlain SR, Won Kim S (2013), “Memantine reduces stealing behavior and impulsivity in kleptomania: a pilot study.” Int Clin Psychopharmacol 28(2):106-11 Details

2012

Cambridge VC, Ziauddeen H, Nathan PJ, Subramaniam N, Dodds C, Chamberlain SR, Koch A, Maltby K, Skeggs AL, Napolitano A, Sadaf Farooqi I, Bullmore ET, Fletcher PC (2012), “Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People.” Biol Psychiatry Details

Chamberlain SR, Mogg K, Bradley BP, Koch A, Dodds CM, Tao WX, Maltby K, Sarai B, Napolitano A, Richards DB, Bullmore ET, Nathan PJ (2012), “Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals.” Psychopharmacology (Berl) Details

Ersche KD, Turton AJ, Chamberlain SR, Müller U, Bullmore ET, Robbins TW (2012), “Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence.” Am J Psychiatry 169(9):926-36 Details

Grant JE, Chamberlain SR, Schreiber L, Odlaug BL (2012), “Neuropsychological deficits associated with cannabis use in young adults.” Drug Alcohol Depend 121(1-2):159-62 Details

Grant JE, Chamberlain SR, Schreiber LR, Odlaug BL (2012), “Gender-related clinical and neurocognitive differences in individuals seeking treatment for pathological gambling.” J Psychiatr Res 46(9):1206-11 Details

Grant JE, Chamberlain SR, Schreiber LR, Odlaug BL (2012), “Neurocognitive deficits associated with shoplifting in young adults.” Compr Psychiatry Details

Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ (2012), “Skin picking disorder.” Am J Psychiatry 169(11):1143-9 Details

Grant JE, Odlaug BL, Chamberlain SR, Schreiber LR (2012), “Neurocognitive dysfunction in strategic and non-strategic gamblers.” Prog Neuropsychopharmacol Biol Psychiatry 38(2):336-40 Details

Grant JE, Odlaug BL, Hampshire A, Schreiber LR, Chamberlain SR (2012), “White Matter Abnormalities in Skin Picking Disorder: A Diffusion Tensor Imaging Study.” Neuropsychopharmacology Details

Lochner C, Fouché JP, du Plessis S, Spottiswoode B, Seedat S, Fineberg N, Chamberlain SR, Stein DJ (2012), “Evidence for fractional anisotropy and mean diffusivity white matter abnormalities in the internal capsule and cingulum in patients with obsessive-compulsive disorder.” J Psychiatry Neurosci 37(3):193-9 Details

Lochner C, Simmons C, Kidd M, Chamberlain SR, Fineberg NA, van Honk J, Ipser J, Stein DJ (2012), “Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder.” Behav Brain Res 226(1):274-80 Details

Odlaug BL, Chamberlain SR, Harvanko AM, Grant JE (2012), “Age at onset in trichotillomania:clinical variables and neurocognitive performance.” Prim Care Companion CNS Disord 14(4) Details

Ziauddeen H, Chamberlain SR, Nathan PJ, Koch A, Maltby K, Bush M, Tao WX, Napolitano A, Skeggs AL, Brooke AC, Cheke L, Clayton NS, Sadaf Farooqi I, O'Rahilly S, Waterworth D, Song K, Hosking L, Richards DB, Fletcher PC, Bullmore ET (2012), “Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects.” Mol Psychiatry Details

2011

Blanchard MM, Chamberlain SR, Roiser J, Robbins TW, Müller U (2011), “Effects of two dopamine-modulating genes (DAT1 9/10 and COMT Val/Met) on n-back working memory performance in healthy volunteers.” Psychol Med 41(3):611-8 Details

Chamberlain SR, Blackwell AD, Nathan PJ, Hammond G, Robbins TW, Hodges JR, Michael A, Semple JM, Bullmore ET, Sahakian BJ (2011), “Differential Cognitive Deterioration in Dementia: A Two Year Longitudinal Study.” J Alzheimers Dis Details

Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW (2011), “The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.” Biol Psychiatry 69(12):e145-57 Details

Fineberg N, Chamberlain S, Hollander E, Boulougouris V, Robbins T (2011), “TRANSLATIONAL APPROACHES TO OBSESSIVE-COMPULSIVE DISORDER: FROM ANIMAL MODELS TO CLINICAL TREATMENT.” Br J Pharmacol Details

Grant JE, Chamberlain SR, Schreiber LR, Odlaug BL, Kim SW (2011), “Selective decision-making deficits in at-risk gamblers.” Psychiatry Res 189(1):115-20 Details

Grant JE, Odlaug BL, Chamberlain SR (2011), “Neurocognitive response to deep brain stimulation for obsessive-compulsive disorder: a case report.” Am J Psychiatry 168(12):1338-9 Details

Grant JE, Odlaug BL, Chamberlain SR (2011), “A cognitive comparison of pathological skin picking and trichotillomania.” J Psychiatr Res 45(12):1634-8 Details

Grant JE, Odlaug BL, Chamberlain SR, Kim SW (2011), “Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study.” Psychopharmacology (Berl) Details

Odlaug BL, Chamberlain SR, Kim SW, Schreiber LR, Grant JE (2011), “A neurocognitive comparison of cognitive flexibility and response inhibition in gamblers with varying degrees of clinical severity.” Psychol Med :1-9 Details

2010

Chamberlain SR, Grant JE, Costa A, Müller U, Sahakian BJ (2010), “Effects of acute modafinil on cognition in trichotillomania.” Psychopharmacology (Berl) 212(4):597-601 Details

Chamberlain SR, Hampshire A, Menzies LA, Garyfallidis E, Grant JE, Odlaug BL, Craig K, Fineberg N, Sahakian BJ (2010), “Reduced brain white matter integrity in trichotillomania: a diffusion tensor imaging study.” Arch Gen Psychiatry 67(9):965-71 Details

Chamberlain SR, Robbins TW, Winder-Rhodes S, Müller U, Sahakian BJ, Blackwell AD, Barnett JH (2010), “Translational Approaches to Frontostriatal Dysfunction in Attention-Deficit/Hyperactivity Disorder Using a Computerized Neuropsychological Battery.” Biol Psychiatry Details

Dittrich WH, Johansen T, Padhi AK, Smith IE, Chamberlain SR, Fineberg NA (2010), “Clinical and neurocognitive changes with modafinil in obsessive-compulsive disorder: a case report.” Psychopharmacology (Berl) 212(3):449-51 Details

Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E (2010), “Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review.” Neuropsychopharmacology 35(3):591-604 Details

Grant JE, Chamberlain SR, Odlaug BL, Potenza MN, Kim SW (2010), “Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study.” Psychopharmacology (Berl) Details

Grant JE, Odlaug BL, Chamberlain SR, Kim SW (2010), “A Double-Blind, Placebo-Controlled Trial of Lamotrigine for Pathological Skin Picking: Treatment Efficacy and Neurocognitive Predictors of Response.” J Clin Psychopharmacol Details

Hampshire A, Chamberlain SR, Monti MM, Duncan J, Owen AM (2010), “The role of the right inferior frontal gyrus: inhibition and attentional control.” Neuroimage 50(3):1313-9 Details

Odlaug BL, Chamberlain SR, Grant JE (2010), “Motor inhibition and cognitive flexibility in pathologic skin picking.” Prog Neuropsychopharmacol Biol Psychiatry 34(1):208-11 Details

2009

Boulougouris V, Chamberlain SR, Robbins TW (2009), “Cross-species models of OCD spectrum disorders.” Psychiatry Res Details

Chamberlain SR, Hampshire A, Müller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJ (2009), “Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.” Biol Psychiatry 65(7):550-5 Details

Chamberlain SR, Menzies L (2009), “Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential.” Expert Rev Neurother 9(8):1133-46 Details

Chamberlain SR, Odlaug BL, Boulougouris V, Fineberg NA, Grant JE (2009), “Trichotillomania: neurobiology and treatment.” Neurosci Biobehav Rev 33(6):831-42 Details

Clark L, Chamberlain SR, Sahakian BJ (2009), “Neurocognitive mechanisms in depression: implications for treatment.” Annu Rev Neurosci 32:57-74 Details

Pallanti S, Castellini G, Chamberlain SR, Quercioli L, Zaccara G, Fineberg NA (2009), “Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms.” Psychiatry Res Details

Winder-Rhodes S, Chamberlain S, Idris M, Robbins T, Sahakian B, Müller U (2009), “Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers.” J Psychopharmacol Details

2008

Chamberlain SR, Menzies L, Hampshire A, Suckling J, Fineberg NA, del Campo N, Aitken M, Craig K, Owen AM, Bullmore ET, Robbins TW, Sahakian BJ (2008), “Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives.” Science 321(5887):421-2 Details

Chamberlain SR, Menzies LA, Fineberg NA, Del Campo N, Suckling J, Craig K, Müller U, Robbins TW, Bullmore ET, Sahakian BJ (2008), “Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study.” Br J Psychiatry 193(3):216-21 Details

Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET (2008), “Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.” Neurosci Biobehav Rev 32(3):525-49 Details

Menzies L, Williams GB, Chamberlain SR, Ooi C, Fineberg N, Suckling J, Sahakian BJ, Robbins TW, Bullmore ET (2008), “White Matter Abnormalities in Patients With Obsessive-Compulsive Disorder and Their First-Degree Relatives.” Am J Psychiatry Details

2007

Chamberlain SR, Del Campo N, Dowson J, Müller U, Clark L, Robbins TW, Sahakian BJ (2007), “Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.” Biol Psychiatry 62(9):977-84 Details

Chamberlain SR, Fineberg NA, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2007), “A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania.” Neuropsychologia 45(4):654-62 Details

Chamberlain SR, Menzies L, Sahakian BJ, Fineberg NA (2007), “Lifting the veil on trichotillomania.” Am J Psychiatry 164(4):568-74 Details

Chamberlain SR, Müller U, Cleary S, Robbins TW, Sahakian BJ (2007), “Atomoxetine increases salivary cortisol in healthy volunteers.” J Psychopharmacol 21(5):545-9 Details

Chamberlain SR, Müller U, Deakin JB, Corlett PR, Dowson J, Cardinal RN, Aitken MR, Robbins TW, Sahakian BJ (2007), “Lack of deleterious effects of buspirone on cognition in healthy male volunteers.” J Psychopharmacol 21(2):210-5 Details

Chamberlain SR, Robbins TW, Sahakian BJ (2007), “The neurobiology of attention-deficit/hyperactivity disorder.” Biol Psychiatry 61(12):1317-9 Details

Chamberlain SR, Sahakian BJ (2007), “The neuropsychiatry of impulsivity.” Curr Opin Psychiatry 20(3):255-61 Details

Fineberg NA, Sharma P, Sivakumaran T, Sahakian B, Chamberlain SR (2007), “Does obsessive-compulsive personality disorder belong within the obsessive-compulsive spectrum?” CNS Spectr 12(6):467-82 Details

Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen CH, del Campo N, Sahakian BJ, Robbins TW, Bullmore E (2007), “Neurocognitive endophenotypes of obsessive-compulsive disorder.” Brain 130(Pt 12):3223-36 Details

2006

Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ (2006), “Strategy implementation in obsessive-compulsive disorder and trichotillomania.” Psychol Med 36(1):91-7 Details

Chamberlain SR, Müller U, Blackwell AD, Robbins TW, Sahakian BJ (2006), “Noradrenergic modulation of working memory and emotional memory in humans.” Psychopharmacology (Berl) 188(4):397-407 Details

Chamberlain SR, Müller U, Robbins TW, Sahakian BJ (2006), “Neuropharmacological modulation of cognition.” Curr Opin Neurol 19(6):607-12 Details

Chamberlain SR, Sahakian BJ (2006), “The neuropsychology of mood disorders.” Curr Psychiatry Rep 8(6):458-63 Details

Stein DJ, Chamberlain SR, Fineberg N (2006), “An A-B-C model of habit disorders: hair-pulling, skin-picking, and other stereotypic conditions.” CNS Spectr 11(11):824-7 Details

2005

Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ (2005), “The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers.” Neurosci Biobehav Rev 29(3):399-419 Details

2004

Chamberlain SR, Sahakian BJ (2004), “Cognition in mania and depression: psychological models and clinical implications.” Curr Psychiatry Rep 6(6):451-8 Details